Citi analyst Christopher Allen raised the firm’s price target on CME Group (CME) to $275 from $265 and keeps a Neutral rating on the shares. The firm, which is updating estimates for current volume and pricing trends, raised its Q2 EPS estimate to $2.91 from $2.88. The firm also raised its 2025, 2026 and 2027 EPS estimates, it noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME: